Now reimag­in­ing home, of­fice sched­ules: No­var­tis CEO Vas Narasimhan sees a new nor­mal in the post-Covid era

It’s not just small biotechs that are looking to completely reevaluate their need for office space in a post-Covid world. It turns out Novartis CEO Vas Narasimhan is also reimagining the Big Pharma footprint in the commercial real estate world.

“We’ve all learned from the pandemic that we can work from home and work from the office, and it will always be a combination going forward,” Narasimhan told Bloomberg Television in an interview.